Reframe Cancer has announced Russell Young as its new commercial director.

He joins from Further Group UK where he was director of sales and account management. In his two and a half years at Further Group he led significant growth with insurers and brokers.

Mark Stepheson, chief executive of Reframe Cancer said: “We’re so pleased to have secured Russell to head up our commercial function. His appointment will help bring innovative solutions across the whole cancer pathway and help us further expand in our designated customer channels. His knowledge of the market mixed with his ethical approach will further help us grow as we continue to expand and invest in new systems.”

Russell’s appointment follows the recent senior hires of Professor Ben Kelly (from Nuffield Health) as chief operating officer and Nikki Cannon who previously led the transformation of personalised care and survivorship at Guy’s and St. Thomas’ NHS Trust, as head of screening.